5 completed, 1 enrolling by invitation. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 5, Enrolling by invitation 1 |
Follow Rigel Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects Fostamatinib, Placebo - Covid19, SARS (Severe Acute Respiratory Syndrome) | Phase 3 | Completed | Rigel Pharmaceuticals | 280 | 2021-03-25 | 2023-08-18 |
| A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia Fostamatinib disodium - Warm Antibody Autoimmune Hemolytic Anemia | Phase 3 | Enrolling by invitation | Rigel Pharmaceuticals | 90 | 2019-10-30 | 2022-03-17 |
| A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA Fostamatinib disodium, Placebo - Warm Antibody Autoimmune Hemolytic Anemia | Phase 3 | Completed | Rigel Pharmaceuticals | 90 | 2019-04-24 | 2023-05-25 |
| A Efficacy and Safety Study of Fostamatinib in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) Fostamatinib Disodium, Placebo - Immune Thrombocytopenic Purpura | Phase 3 | Completed | Rigel Pharmaceuticals | 74 | 2015-01-01 | 2019-01-25 |
| Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) Fostamatinib Disodium - Immune Thrombocytopenic Purpura | Phase 3 | Completed | Rigel Pharmaceuticals | 123 | 2014-10-01 | 2023-12-11 |
| A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) Fostamatinib disodium, Placebo - Immune Thrombocytopenic Purpura | Phase 3 | Completed | Rigel Pharmaceuticals | 76 | 2014-07-14 | 2019-02-12 |
Purpura, Thrombocytopenic, Idiopathic (3) · COVID-19 (1) · Pneumonia (1) · Pneumonia, Viral (1) · Severe Acute Respiratory Syndrome (1)
fostamatinib (6)
United States (6) · Australia (4) · Austria (4) · Bulgaria (4) · Czechia (4) · Italy (4) · Netherlands (4) · Norway (4) · Spain (4) · United Kingdom (4) · Canada (3) · Denmark (3) · Germany (3) · Hungary (3) · Romania (3)